Back to Startups

Aqtual

Software
Software Show less
Software
Software Show less
Website LinkedIn 31145 San Antonio St, Hayward, CA 94544
About Aqtual

Aqtual's mission is to revolutionize chronic disease and oncology management by bridging the translational gap between groundbreaking research and practical applications. The company utilizes a novel cell-free DNA platform to develop precision medicine solutions aimed at improving patient outcomes in chronic diseases and oncology.

Business Information
Target Customers
healthcare providers research institutions biotechnology companies
Industry Categories
Software
Business Model
Revenue Model B2B
Pricing Strategy N/A
Sales Channels direct sales, partnerships with healthcare institutions
Funding Timeline
Round Date Amount Investors
Series B Jul 11, 2025 $31.0M Unknown
Founders

No founder information available.

Investors

No investor information available.

Recent Mentions
raisingfi
Raising.fi @raisingfi
Jul 11, 2025

New Raise 🏛️ Company: Aqtual 🔗 Website: https://t.co/8QZWo8H5yX 📊 Amount: $31 Million 🔄 Round: Series B 🧮 Valuation: N/A ⚙️ Industry: Healthcare

View on Twitter
Similar Startups
ProteinQure
85% match

ProteinQure is a biotechnology startup focused on revolutionizing the design and optimization of pro...
AusperBio
85% match

A clinical-stage biotechnology company dedicated to advancing targeted oligonucleotide therapies.
PAQ Therapeutics
85% match

A biotechnology company developing KRAS degraders for deadly cancers without good treatment options.
Altera Biosciences
85% match

Developing universal donor cell therapies that bypass immune rejection.